Literature DB >> 18603060

Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants.

David A Hehir1, Troy E Dominguez, Jean A Ballweg, Chitra Ravishankar, Bradley S Marino, Geoffrey L Bird, Susan C Nicolson, Thomas L Spray, J William Gaynor, Sarah Tabbutt.   

Abstract

OBJECTIVE: The risk of death during the interstage period remains high after stage 1 reconstruction for single ventricle lesions, despite improved surgical results. The purpose of this study is to identify risk factors for interstage death and to describe the events leading to interstage death.
METHODS: A nested case-control study was conducted of 368 patients who underwent stage 1 reconstruction at a single center between January 1998 and April 2005.
RESULTS: Among the 313 (85%) hospital survivors, there were 33 (10.5%) interstage deaths. Cases more frequently presented with intact or restrictive atrial septum (9 [27%] vs 4 [4%]; P < .001), were older at the time of surgery (5 [2-40] vs 3 [1-42] days; P = .005), had more postoperative arrhythmias (12 [36%] vs 15 [15%]; P = .01), and a higher incidence of airway or respiratory complications (12 [36%] vs 19 [19%]; P = .04). By multivariate analysis, only intact atrial septum (odds ratio 7.6; 95% confidence intervals 1.9-29.6; P = .003) and age at operation greater than 7 days (odds ratio 3.8; 95% confidence intervals 1.3-11.2; P = .017) were predictors of interstage death.
CONCLUSIONS: The presence of intact atrial septum and older age at the time of surgery are associated with a higher risk of interstage death. In addition, postoperative arrhythmia and airway complications are associated with a higher risk of interstage death in univariate analysis. The results of this study provide a focus for interstage monitoring and risk stratification of these high-risk infants, which may improve overall survival.

Entities:  

Mesh:

Year:  2008        PMID: 18603060     DOI: 10.1016/j.jtcvs.2007.12.012

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  47 in total

1.  Complications after the Norwood operation: an analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  Christoph P Hornik; Xia He; Jeffrey P Jacobs; Jennifer S Li; Robert D B Jaquiss; Marshall L Jacobs; Sean M O'Brien; Eric D Peterson; Sara K Pasquali
Journal:  Ann Thorac Surg       Date:  2011-09-19       Impact factor: 4.330

2.  Regionalization in neonatal congenital heart surgery: the impact of distance on outcome after discharge.

Authors:  Nelangi M Pinto; Javier Lasa; Troy E Dominguez; Gil Wernovsky; Sarah Tabbutt; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2011-09-29       Impact factor: 1.655

3.  Comparison of shunt types in the Norwood procedure for single-ventricle lesions.

Authors:  Richard G Ohye; Lynn A Sleeper; Lynn Mahony; Jane W Newburger; Gail D Pearson; Minmin Lu; Caren S Goldberg; Sarah Tabbutt; Peter C Frommelt; Nancy S Ghanayem; Peter C Laussen; John F Rhodes; Alan B Lewis; Seema Mital; Chitra Ravishankar; Ismee A Williams; Carolyn Dunbar-Masterson; Andrew M Atz; Steven Colan; L LuAnn Minich; Christian Pizarro; Kirk R Kanter; James Jaggers; Jeffrey P Jacobs; Catherine Dent Krawczeski; Nancy Pike; Brian W McCrindle; Lisa Virzi; J William Gaynor
Journal:  N Engl J Med       Date:  2010-05-27       Impact factor: 91.245

4.  Enalapril in infants with single ventricle: results of a multicenter randomized trial.

Authors:  Daphne T Hsu; Victor Zak; Lynn Mahony; Lynn A Sleeper; Andrew M Atz; Jami C Levine; Piers C Barker; Chitra Ravishankar; Brian W McCrindle; Richard V Williams; Karen Altmann; Nancy S Ghanayem; Renee Margossian; Wendy K Chung; William L Border; Gail D Pearson; Mario P Stylianou; Seema Mital
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

5.  Interstage Weight Gain Is Associated With Survival After First-Stage Single-Ventricle Palliation.

Authors:  Charles F Evans; John D Sorkin; Danielle S Abraham; Brody Wehman; Sunjay Kaushal; Geoffrey L Rosenthal
Journal:  Ann Thorac Surg       Date:  2017-03-24       Impact factor: 4.330

6.  Risk Factors for Development of Ectopic Atrial Tachycardia in Post-operative Congenital Heart Disease.

Authors:  Bradley C Clark; John T Berger; Charles I Berul; Richard A Jonas; Jonathan R Kaltman; Julianne Lapsa; Dilip S Nath; Elizabeth D Sherwin; Pranava Sinha; David Zurakowski; Jeffrey P Moak
Journal:  Pediatr Cardiol       Date:  2017-11-17       Impact factor: 1.655

7.  Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry: a report from the national pediatric cardiology-quality improvement collaborative.

Authors:  Russell R Cross; Ashraf S Harahsheh; Robert McCarter; Gerard R Martin
Journal:  Cardiol Young       Date:  2013-02-06       Impact factor: 1.093

8.  Factors associated with serum B-type natriuretic peptide in infants with single ventricles.

Authors:  Ryan J Butts; Victor Zak; Daphne Hsu; James Cnota; Steven D Colan; David Hehir; Paul Kantor; Jami C Levine; Renee Margossian; Marc Richmond; Anita Szwast; Derek Williams; Richard Williams; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2014-02-13       Impact factor: 1.655

9.  Cause, timing, and location of death in the Single Ventricle Reconstruction trial.

Authors:  Richard G Ohye; Julie V Schonbeck; Pirooz Eghtesady; Peter C Laussen; Christian Pizarro; Peter Shrader; Deborah U Frank; Eric M Graham; Kevin D Hill; Jeffrey P Jacobs; Kirk R Kanter; Joel A Kirsh; Linda M Lambert; Alan B Lewis; Chitra Ravishankar; James S Tweddell; Ismee A Williams; Gail D Pearson
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-15       Impact factor: 5.209

10.  Congenital heart disease in low-birth-weight infants: effects of small for gestational age (SGA) status and maturity on postoperative outcomes.

Authors:  Daniel Wei; Colleen Azen; Shazia Bhombal; Laura Hastings; Lisa Paquette
Journal:  Pediatr Cardiol       Date:  2014-07-06       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.